151 related articles for article (PubMed ID: 27030405)
1. KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles.
Bari R; Thapa R; Bao J; Li Y; Zheng J; Leung W
Sci Rep; 2016 Mar; 6():23689. PubMed ID: 27030405
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
3. Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for staining.
Falco M; Romeo E; Marcenaro S; Martini S; Vitale M; Bottino C; Mingari MC; Moretta L; Moretta A; Pende D
J Immunol; 2010 Jul; 185(1):433-41. PubMed ID: 20525888
[TBL] [Abstract][Full Text] [Related]
4. Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals.
Cassidy S; Mukherjee S; Myint TM; Mbiribindi B; North H; Traherne J; Mulder A; Claas FH; Purbhoo MA; Das J; Khakoo SI
Eur J Immunol; 2015 Feb; 45(2):492-500. PubMed ID: 25359276
[TBL] [Abstract][Full Text] [Related]
5. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.
Moesta AK; Norman PJ; Yawata M; Yawata N; Gleimer M; Parham P
J Immunol; 2008 Mar; 180(6):3969-79. PubMed ID: 18322206
[TBL] [Abstract][Full Text] [Related]
6. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
7. Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand.
Frazier WR; Steiner N; Hou L; Dakshanamurthy S; Hurley CK
J Immunol; 2013 Jun; 190(12):6198-208. PubMed ID: 23686481
[TBL] [Abstract][Full Text] [Related]
8. Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-C.
Hilton HG; Blokhuis JH; Guethlein LA; Norman PJ; Parham P
J Immunol; 2017 Mar; 198(5):1961-1973. PubMed ID: 28122963
[No Abstract] [Full Text] [Related]
9. Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand.
Hollenbach JA; Ladner MB; Saeteurn K; Taylor KD; Mei L; Haritunians T; McGovern DP; Erlich HA; Rotter JI; Trachtenberg EA
Immunogenetics; 2009 Oct; 61(10):663-71. PubMed ID: 19789864
[TBL] [Abstract][Full Text] [Related]
10. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K
Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121
[TBL] [Abstract][Full Text] [Related]
11. Allelic polymorphism of KIR2DL2/2DL3 in a southern Chinese population.
Zhen J; He L; Xu Y; Zhao J; Yu Q; Zou H; Sun G; Deng Z
Tissue Antigens; 2015 Nov; 86(5):362-7. PubMed ID: 26423800
[TBL] [Abstract][Full Text] [Related]
12. Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C.
Moradi S; Stankovic S; O'Connor GM; Pymm P; MacLachlan BJ; Faoro C; Retière C; Sullivan LC; Saunders PM; Widjaja J; Cox-Livingstone S; Rossjohn J; Brooks AG; Vivian JP
Nat Commun; 2021 Apr; 12(1):2173. PubMed ID: 33846289
[TBL] [Abstract][Full Text] [Related]
13. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
[TBL] [Abstract][Full Text] [Related]
14. The Interaction of HLA-C1/KIR2DL2/L3 Promoted KIR2DL2/L3 Single-Positive/NKG2C-Positive Natural Killer Cell Reconstitution, Raising the Incidence of aGVHD after Hematopoietic Stem Cell Transplantation.
Zuo W; Yu XX; Liu XF; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Zhao XS; Huang XJ; Zhao XY
Front Immunol; 2022; 13():814334. PubMed ID: 35572602
[TBL] [Abstract][Full Text] [Related]
15. Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA-C1 ligand binding.
Ramos-Lopez E; Scholten F; Aminkeng F; Wild C; Kalhes H; Seidl C; Tonn T; Van der Auwera B; Badenhoop K
Tissue Antigens; 2009 Jun; 73(6):599-603. PubMed ID: 19392800
[TBL] [Abstract][Full Text] [Related]
16. Investigation of killer cell immunoglobulin-like receptors KIR2DL2 and KIR2DL3 diversity and identification of ten novel KIR2DL3 alleles in the Chinese Han population.
He Y; Tao S; Ying Y; He J; Zhu F; Lv H
Scand J Immunol; 2015 Apr; 81(4):265-71. PubMed ID: 25651940
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population.
Auer ED; Tong HV; Amorim LM; Malheiros D; Hoan NX; Issler HC; Petzl-Erler ML; Beltrame MH; Boldt ABW; Toan NL; Song LH; Velavan TP; Augusto DG
Int J Infect Dis; 2020 Jul; 96():541-547. PubMed ID: 32422377
[TBL] [Abstract][Full Text] [Related]
18. Significant association of the KIR2DL3/HLA-C1 genotype with susceptibility to Crohn's disease.
Díaz-Peña R; Vidal-Castiñeira JR; Moro-García MA; Alonso-Arias R; Castro-Santos P
Hum Immunol; 2016 Jan; 77(1):104-109. PubMed ID: 26542067
[TBL] [Abstract][Full Text] [Related]
19. Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.
Romagné F; André P; Spee P; Zahn S; Anfossi N; Gauthier L; Capanni M; Ruggeri L; Benson DM; Blaser BW; Della Chiesa M; Moretta A; Vivier E; Caligiuri MA; Velardi A; Wagtmann N
Blood; 2009 Sep; 114(13):2667-77. PubMed ID: 19553639
[TBL] [Abstract][Full Text] [Related]
20. HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2
Wauquier N; Petitdemange C; Tarantino N; Maucourant C; Coomber M; Lungay V; Bangura J; Debré P; Vieillard V
EBioMedicine; 2019 Feb; 40():605-613. PubMed ID: 30711514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
